NCT06376682 2025-09-22
EPIBONE
Quantum Surgical
Phase NA Completed
Clinical Trials
13 trialsNCT05847868 2025-07-03
KRIOS
Estas Tıbbi Mamülleri Medikal
Phase NA Completed
NCT04256993 2024-01-16
PRECISE
Bayer
Completed
NCT00321464 2022-11-08
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Amgen
Phase 3 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT01343693 2020-01-06
MaxAn
Zimmer Biomet
Completed
NCT03076138 2019-05-07
Gene-activated Bone Substitute for Maxillofacial Bone Regeneration
Histograft Co., Ltd.
Phase NA Completed
NCT00321620 2018-08-29
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Amgen
Phase 3 Completed
NCT02575352 2018-05-25
CPC
Graftys SA
Unknown
NCT01920568 2017-01-16
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
GlaxoSmithKline
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT01214291 2013-11-15
TREAT2
GTx
Phase 3 Withdrawn
NCT00859560 2009-03-11
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
AstraZeneca
Completed